iBio (IBIO) Accounts Payables (2011 - 2026)
iBio's Accounts Payables was $4.42 million in fiscal Q4 2026 (quarter ended Jun 30, 2026), up 102.1% from $2.19 million a year earlier and up 45.7% from the prior quarter.
Powered by 
Analysis
iBio (IBIO) Accounts Payables (2011 - 2026) Analysis & Trends
From fiscal Q4 2011 onward, iBio has reported Accounts Payables for 61 quarters.
- Accounts Payables shows a five-year compound annual growth rate of 14.4% (FY2021 to FY2026).
- In earlier fiscal years, Accounts Payables was $2.19 million in FY2025 (+511.2%), $358,000 in FY2024 (-80.6%), $1.85 million in FY2023 (-56.6%) and $4.26 million in FY2022 (+89.2%).
- The fiscal Q4 2026 figure marks the highest quarterly Accounts Payables since fiscal Q1 2023.
- Compared with a year earlier, Accounts Payables has increased for six straight quarters, with growth averaging 147.4% over the last eight quarters.
- The best year-over-year quarter for Accounts Payables over five years was fiscal Q4 2025 (growth of 511.2%); the worst was fiscal Q4 2024 (a decline of 80.6%).
- Per Business Quant data, IBIO's Accounts Payables in the three fiscal quarters before Q4 2026 was $3.04 million (Q3 2026), $2.65 million (Q2 2026) and $2.82 million (Q1 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.90 Bn | 1,105.48 Bn | 19.71 Bn | 6.11 Bn |
| 2 | Johnson & Johnson | 617.06 Bn | 535.59 Bn | 17.26 Bn | 9.22 Bn |
| 3 | AbbVie | 501.38 Bn | 474.49 Bn | 12.70 Bn | 33.30 Bn |
| 4 | Merck | 367.41 Bn | 321.79 Bn | 12.21 Bn | 3.83 Bn |
| 5 | Novartis Ag | 297.92 Bn | 261.91 Bn | 11.24 Bn | 4.26 Bn |
| 6 | Astrazeneca | 261.31 Bn | 235.00 Bn | 12.86 Bn | 22.89 Bn |
| 7 | Amgen | 236.29 Bn | 191.69 Bn | 7.24 Bn | 2.87 Bn |
| 8 | Gilead Sciences | 190.40 Bn | 164.60 Bn | 6.22 Bn | 674.00 Mn |
| 9 | Pfizer | 169.55 Bn | 116.19 Bn | 10.94 Bn | 4.58 Bn |
| 10 | iBio | 88.65 Mn | -176.56 Mn | - | 4.42 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 4.42 Mn |
| Mar 31, 2026 | 3.04 Mn |
| Dec 31, 2025 | 2.65 Mn |
| Sep 30, 2025 | 2.82 Mn |
| Jun 30, 2025 | 2.19 Mn |
| Mar 31, 2025 | 1.48 Mn |
| Dec 31, 2024 | 614,000.00 |
| Sep 30, 2024 | 855,000.00 |
| Jun 30, 2024 | 358,000.00 |
| Mar 31, 2024 | 1.23 Mn |
| Dec 31, 2023 | 1.86 Mn |
| Sep 30, 2023 | 1.91 Mn |
| Jun 30, 2023 | 1.85 Mn |
| Mar 31, 2023 | 2.01 Mn |
| Dec 31, 2022 | 4.00 Mn |
| Sep 30, 2022 | 4.81 Mn |
| Jun 30, 2022 | 4.26 Mn |
| Mar 31, 2022 | 5.28 Mn |
| Dec 31, 2021 | 2.74 Mn |
| Sep 30, 2021 | 2.29 Mn |
API Access
iBio Accounts Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=accounts-payables&ticker=IBIO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "accounts-payables", "ticker": "IBIO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=accounts-payables&ticker=IBIO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();